Abstract:CNCP patients using BZDs daily represent a high-risk group with multiple comorbid mental health conditions and higher rates of emergency health care use. The high prevalence of BZD use is inconsistent with guidelines for the management of CNCP or chronic mental health conditions.
“…It is well‐known that opioid users, especially long‐term high dose opioid users, have increased risks for co‐medication with BZDs or Z‐hypnotics compared with non‐opioid users . Likewise, in our study, high‐dose opioid users were also high‐dose users of sedative.…”
Many patients who developed recurrent opioid use received prescriptions which substantially conflicted with existing guidelines and might lead to problematic opioid use.
“…It is well‐known that opioid users, especially long‐term high dose opioid users, have increased risks for co‐medication with BZDs or Z‐hypnotics compared with non‐opioid users . Likewise, in our study, high‐dose opioid users were also high‐dose users of sedative.…”
Many patients who developed recurrent opioid use received prescriptions which substantially conflicted with existing guidelines and might lead to problematic opioid use.
“…10,11,28,29 and we found that hypnotics and skeletal muscle relaxants were also associated with longer opioid durations and co-prescribing these drugs have also been shown to be associated with opioid use. 6,15,25 Our analyses show that the likelihood of opioid discontinuation is slowly increasing with time (HR=1.02 in 2007 vs HR=1.11 in 2014) which suggests that prescribers may be becoming more aware of the harms of long-term opioid use.…”
The relationships of characteristics of the initial opioid prescription and pain etiology with the probability of opioid discontinuation were explored in this retrospective cohort study using health insurance claims data from a nationally representative database of commercially insured patients in the U.S. We identified 1,353,902 persons aged ≥14 with no history of cancer or substance abuse, with new opioid use episodes and categorized them into 11 mutually exclusive pain etiologies. Cox Proportional Hazards models were estimated to identify factors associated with time to opioid discontinuation. After accounting for losses to follow-up, the probability of continued opioid use at one year was 5.3% across all subjects. Patients with chronic pain had the highest probability for continued opioid use followed by patients with inpatient admissions. Patients prescribed doses above 90 morphine milligram equivalents (HR=0.91, CI: 0.91–0.92); initiated on tramadol (HR=0.90, CI: 0.89–0.91) or long-acting opioids (HR=0.78, CI: 0.75–0.80); were less likely to discontinue opioids. Increasing days’ supply of the first prescription was consistently associated with a lower likelihood of opioid discontinuation (HRs, CIs: 3–4 days’ supply = 0.70, 0.70–0.71; 5–7 days’ supply = 0.48, 0.47–0.48; 8–10 days’ supply = 0.37, 0.37–0.38; 11–14 days’ supply = 0.32, 0.31–0.33; 15–21 days’ supply = 0.29, 0.28– 0.29; ≥22 days supplied = 0.20, 0.19–0.20). The direction of this relationship was consistent across all pain etiologies. Clinicians should initiate patients with the lowest supply of opioids to mitigate unintentional long term opioid use.
“…More specifically, the study used data from 16 years of the National Health and Nutritional Examination Survey (NHANES) for years 1999 to 2014 to examine trends in use of prescription opioids as well as long‐term use of opioids. In addition, associations of long‐term use with indicators of elevated risk of adverse effects from opioid treatment were examined, including presence of painful conditions, severe medical conditions, concomitant use of benzodiazepines, and history of heroin and alcohol misuse …”
The findings highlight the need for research on potential benefits and harms of long-term use of opioids and efforts to restrict long-term use to patients for whom the benefits outweigh the risks.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.